NASDAQ:HRTX

Heron Therapeutics Stock Forecast

etoro logo Buy HRTX
*Your capital is at risk
$0.427
-0.0561 (-11.60%)
At Close: Jun 05, 2026
AI Analysis AI Analysis of HRTX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add HRTX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

High volatility in Heron Therapeutics stock price on Friday which ended trading at $0.427
(Updated on Jun 05, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since May 08, 2026 Loss -64.68%

The Heron Therapeutics stock price fell by -11.60% on the last day (Friday, 5th Jun 2026) from $0.484 to $0.427. During the last trading day the stock fluctuated 14.67% from a day low at $0.420 to a day high of $0.482. The price has fallen in 7 of the last 10 days and is down by -50.94% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -639 thousand shares and in total, 4 million shares were bought and sold for approximately $1.87 million.

Given the current short-term trend, the stock is expected to fall -3.60% during the next 3 months and, with a 90% probability hold a price between $0.412 and $1.25 at the end of this 3-month period.

HRTX Signals & Forecast

There are few to no technical positive signals at the moment. The Heron Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.628 and $0.96. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, May 06, 2026, and so far it has fallen -67.37%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Heron Therapeutics stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0616 between high and low, or 14.67%. For the last week, the stock has had daily average volatility of 22.41%.

Heron Therapeutics is oversold on RSI14 (18). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (HRTX) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Heron Therapeutics to open at $0.443, and during the day (based on 14 day Average True Range), to move between $0.386 and $0.469, which gives a possible trading interval of +/-$0.0838 (+/-21.73%) up or down from last closing price. If Heron Therapeutics takes out the full calculated possible swing range there will be an estimated 21.73% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.447, some $0.0194 (4.54%) from the current price of $0.427, our system finds the risk reward not very attractive.

Is Heron Therapeutics stock A Buy?

Heron Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.375 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $0.443 ( 3.63%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

HRTX Performance

Trading levels for HRTX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.505 18.05%
R2 0.481 12.54%
R1 0.466 9.14%
Price 0.427
S1 0.419 -1.87%
S2 0.405 -5.27%
S3 0.381 -10.78%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.484 13.13%
R2 0.450 5.29%
R1 0.447 4.54%
Price 0.427
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Heron Therapeutics Stock and on which exchange is it traded?
The symbol for Heron Therapeutics is HRTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Heron Therapeutics Stock?
Heron Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy Heron Therapeutics Stock?
Heron Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Heron Therapeutics Stock.

What's the current price of Heron Therapeutics Stock?
As of the end of day on the Jun 05, 2026, the price of an Heron Therapeutics (HRTX) share was $0.427.

What is the 52-week high and low for Heron Therapeutics Stock?
The 52-week high for Heron Therapeutics Stock is $2.30 and the 52-week low is $0.420.

What is the market capitalization of Heron Therapeutics Stock?
As of the Jun 05, 2026, the market capitalization of Heron Therapeutics is 67.504M.

When is the next earnings date for Heron Therapeutics?
The upcoming earnings date for Heron Therapeutics is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT HERON THERAPEUTICS
Heron Therapeutics
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acut...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
SAP
$172.39
7.18% May 05
FIZZ
$34.11
7.04% May 01
ADBE
$243.57
3.23% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE